Cite This Page
Bibliographic details for Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic
- Page name: Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 25 January 2024 11:46 UTC
- Date retrieved: 13 June 2024 13:28 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751
- Page Version ID: 615751
Citation styles for Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic
APA style
Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic. (2024, January 25). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 13:28, June 13, 2024 from https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751.
MLA style
"Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 25 Jan 2024, 11:46 UTC. 13 Jun 2024, 13:28 <https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 25 January 2024, 11:46 UTC, <https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751> [accessed 13 June 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751 (accessed June 13, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 25, 11:46 UTC [cited 2024 Jun 13]. Available from: https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751.
Bluebook style
Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic, https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751 (last visited June 13, 2024).
BibTeX entry
@misc{ wiki:xxx,
author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
title = "Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
year = "2024",
url = "https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751",
note = "[Online; accessed 13-June-2024]"
}
When using the LaTeX package url (\usepackage{url} somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx,
author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK",
title = "Vemurafenib gives a speedy and powerful scientific response throughout child fluid warmers Langerhans cell histiocytosis with the BRAF V600E mutation yet wont remove lowlevel minimal residual ailment every ddPCR making use of cellfree circulating Genetic --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ",
year = "2024",
url = "\url{https://news.npo.digital/index.php?title=Vemurafenib_gives_a_speedy_and_powerful_scientific_response_throughout_child_fluid_warmers_Langerhans_cell_histiocytosis_with_the_BRAF_V600E_mutation_yet_wont_remove_lowlevel_minimal_residual_ailment_every_ddPCR_making_use_of_cellfree_circulating_Genetic&oldid=615751}",
note = "[Online; accessed 13-June-2024]"
}
